The FY2025 (Dec) proxy of Xencor names 16 peer companies for pay. Pay versus performance data of Xencor for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Revolution Medicines | ||
| Arcus Biosciences | ||
| IDEAYA Biosciences | ||
| Arvinas | ||
| Denali Therapeutics | ||
| Kura Oncology | ||
| Relay Therapeutics | ||
| Agenus, Inc. | Not disclosed | Not disclosed |
| Alector, Inc. | Not disclosed | Not disclosed |
| Allogene Therapeutics, Inc. | Not disclosed | Not disclosed |
| Corcept Therapeutics | Not disclosed | Not disclosed |
| Deciphera Pharmaceuticals | Not disclosed | Not disclosed |
| IGM Biosciences, Inc. | Not disclosed | Not disclosed |
| Inhibrx, Inc. | Not disclosed | Not disclosed |
| Iovance Biotherapeutics | Not disclosed | Not disclosed |
| SpringWorks Therapeutics, Inc. | Not disclosed | Not disclosed |
16 companies
Changes by year
FY2024 (Dec) proxy
- AddedIGM Biosciences, Inc.pay peer group
- AddedInhibrx, Inc.pay peer group
- AddedRelay Therapeuticspay peer group
- AddedSpringWorks Therapeutics, Inc.pay peer group
- RemovedSangamo Therapeutics, Inc.pay peer group
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.